Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Chronic Thrombocytopenia in Children: What Could It Hide?

Sara Mohamed, MD, Martina Di Palma, MD, Michela Faleschini, Daniela De Benedittis, MD, Maria Luisa Moleti, MD, Luisa Cardarelli, MD, Anna Maria Testi, MD, Giovanna Palumbo, MD, Anna Savoia, Fiorina Giona, MD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-138651

Published: 2020

Journal Articles

Role of Blinatumomab in Minimal Residual Disease and Hematologic Relapsed/Refractory Adult Acute Lymphoblastic Leukemia Patients Treated over 5 Years. a Single Center Experience

Michela Ansuinelli, MD, Antonella Vitale, MD, Giovanna Pecoraro, MD, Saveria Capria, MD, Silvia Maria Trisolini, MD, Clara Minotti, MD, Claudio Cartoni, MD, Anna Maria Testi, MD, Maria Luisa Moleti, MD, Anna Paola Iori, MD, Walter Barberi, MD PhD, Irene Della Starza, PhD, Loredana Elia, Bs, Francesca Mancini, Maria Stefania De Propris, Anna Guarini, PhD, Sabina Chiaretti, MD PhD, Robin Foà, MD

Blood (2019) 134 (Supplement_1): 5121.

https://doi.org/10.1182/blood-2019-128156

Published: 2019

Journal Articles

Specific Guidelines Including Multidisciplinary Approach Is Critical of Management of Langerhans Cell Histiocytosis in Adults

Lorenzo Rizzo, Michelina Santopietro, MD, Gianluca Sfaciotti, MD, Marco Brunori, MD, Luisa Cardarelli, MD, Giovanna Palumbo, MD, Daniela De Benedittis, MD, Martina Di Palma, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Tiziana Di Pippo, Fiorina Giona, MD

Blood (2019) 134 (Supplement_1): 1041.

https://doi.org/10.1182/blood-2019-129707

Published: 2019

Journal Articles

Next-Generation Sequencing (NGS) in Childhood Myeloproliferative Diseases (MPD)

Michelina Santopietro, MD, Giovanna Palumbo, MD, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Luisa Cardarelli, MD, Nicola Monaco, MDcal Student, Francesco Malaspina, MD, Camilla Presicce, MDcal Student, Sonia Maria Orlando, Alessandro Pancrazzi, PhD, Annalisa Pacilli, PhD, Giada Rotunno, PhD, Alessandro M. Vannucchi, MD, Robin Foà, MD, Fiorina Giona, MD

Blood (2018) 132 (Supplement 1): 3049.

https://doi.org/10.1182/blood-2018-99-118102

Published: 2018

Journal Articles

Intermittent Imatinib Mesylate in Children with Chronic Myeloid Leukemia: Results and Outcome

Francesco Malaspina, MD, Maria Caterina Putti, MD, Michelina Santopietro, MD, Saverio Ladogana, MD, Rosamaria Mura, MD, Roberta Burnelli, MD, Nadia Vacca, MD, Lorenzo Rizzo, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Andrea Biondi, Franco Locatelli, Giuseppe Saglio, Robin Foà, MD, Fiorina Giona, MD

Blood (2018) 132 (Supplement 1): 4256.

https://doi.org/10.1182/blood-2018-99-118030

Published: 2018

Journal Articles

Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib— the Italian Experience

Blood (2017) 130 (Supplement 1): 1600.

https://doi.org/10.1182/blood.V130.Suppl_1.1600.1600

Published: 2017

Journal Articles

Management of Chronic Myeloid Leukemia in Children and Adolescents According to Local Guidelines.the Italian Experience

Blood (2016) 128 (22): 3083.

https://doi.org/10.1182/blood.V128.22.3083.3083

Published: 2016

Journal Articles

Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. the Italian Experience

Blood (2015) 126 (23): 2788.

https://doi.org/10.1182/blood.V126.23.2788.2788

Published: 2015

Journal Articles

Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience

Blood (2014) 124 (21): 1812.

https://doi.org/10.1182/blood.V124.21.1812.1812

Published: 2014

Journal Articles

Primary Trombocythemia in Children and Adolescents Includes Different Subtypes Compared to Adult Essential Thrombocythemia

Fiorina Giona, MD, Marica Laurino, Luciana Teofili, MD PhD, Sara Capodimonti, BSc, PhD, Maurizio Martini, MD PhD, Giovanna Palumbo, MD, Maria Luisa Moleti, MD, Deborah Marzella, MD, Daniela Diverio, Maria Grazia Mascolo, Luigi Maria Larocca, MD, Robin Foà, MD

Blood (2014) 124 (21): 1865.

https://doi.org/10.1182/blood.V124.21.1865.1865

Published: 2014

Journal Articles

Can Children and Adolescents With Chronic Myelogenous Leukemia Be Cured Without Stem Cell Transplant? A Single Center Experience

Fiorina Giona, Benedetta Siniscalchi, Maria Luisa Moleti, Massimiliano Rea, Deborah Marzella, Mauro Nanni, Enrico Gottardi, Anna Paola Iori, Daniela Diverio, Anna Maria Testi, Giuseppe Saglio, MD, Robin Foa'

Blood (2013) 122 (21): 4033.

https://doi.org/10.1182/blood.V122.21.4033.4033

Published: 2013

Journal Articles

Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome

Fiorina Giona, Luciana Teofili, Maria Luisa Moleti, Maurizio Martini, Giovanna Palumbo, Angela Amendola, Maria Gabriella Mazzucconi, Anna Maria Testi, Patrizia Pignoloni, Sonia Maria Orlando, Sara Capodimonti, Mauro Nanni, Giuseppe Leone, Luigi Maria Larocca, Robin Foà

Blood (2012) 119 (10): 2219–2227.

https://doi.org/10.1182/blood-2011-08-371328

Published: 2012

Includes: Supplemental data

Journal Articles

Incidence and Predictors of Early Treatment-Related Mortality In Pediatric Acute Lymphoblastic Leukemia In Baghdad (Iraq)

Anna Maria Testi, Robin Foa, Mazin Faisal Al-Jadiry, Maria Luisa Moleti, Salma Abbas Al-Hadad, Jawad Kadhum Al-Taee, Wisam Majeed Abed, Najiha Ahmed Ameen, Hasanein H. Ghali, Amir Fadhil Al-Darraji, Raghad Majid Al-Saeed, Valerio Cecinati, Annalisa De Vellis, Alfonso Piciocchi

Blood (2010) 116 (21): 2132.

https://doi.org/10.1182/blood.V116.21.2132.2132

Published: 2010

Journal Articles

GIMEMA-AIEOP AIDA Protocols for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) In Children: Analysis of 247 Patients Enrolled In Two Sequential Italian Multicenter Trials

Anna Maria Testi, Robin Foa, Gabriella Tomei, Francesco Lo Coco, Andrea Biondi, MD, Andrea Pession, Daniela Diverio, Marco Vignetti, Giuseppe Basso, Franco Locatelli, MD, FRCPath, Carmelo Rizzari, Giuseppe Menna, Maria Luisa Moleti, Nicola Santoro, Giuseppe Fioritoni, Riccardo Masetti, Franco Mandelli

Blood (2010) 116 (21): 871.

https://doi.org/10.1182/blood.V116.21.871.871

Published: 2010

Journal Articles

Clinical and Biological Features, Treatment and Long-Term Outcome of 65 Children with Ph- Myeloprolipherative Disorders (MPD).

Fiorina Giona, Luciana Teofili, Giovanna Palumbo, Maria Luisa Moleti, Massimiliano Rea, Sonia Maria Orlando, Vittorio Nunes, Anna Maria Testi, Valerio Cecinati, MD, Sara Capodimonte, Mauro Nanni, Luigi Maria Larocca, Robin Foà

Blood (2009) 114 (22): 1889.

https://doi.org/10.1182/blood.V114.22.1889.1889

Published: 2009

Journal Articles

Inherited and Acquired Thrombophilic Abnormalities in Patients Aged <20 Years with Bcr-Abl Negative Chronic Myeloproliferative Disorders

Fiorina Giona, Angela Amendola, Giovanna Palumbo, Patrizia Pignoloni, Antonio Chistolini, Maria Luisa Moleti, Robert Foà, Maria Gabriella Mazzucconi

Blood (2008) 112 (11): 5249.

https://doi.org/10.1182/blood.V112.11.5249.5249

Published: 2008

Journal Articles

Imatinib Mesylate Induces High Complete Cytogenetic and Molecular Response Rates in Children and Adolescents with Philadelphia Chromosome-Positive (Ph + ) Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP)

Fiorina Giona, Maria Caterina Putti, Maria Luisa Moleti, Mauro Nanni, Anna Maria Testi, Stefania Varotto, Enrico Marco Gottardi, Annalisa De Vellis, Vittorio Nunes, Daniela Diverio, Anna Leszl, Giuseppe Saglio, MD, Robert Foà

Blood (2008) 112 (11): 4273.

https://doi.org/10.1182/blood.V112.11.4273.4273

Published: 2008

Journal Articles

Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.

Fiorina Giona, MD, Stefania Mariani, MD, Annalisa De Vellis, MD, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Mariella D’Angiò, MD, Bruna De Masi, MD, Robert Foa, MD, Lucio Gnessi, MD

Blood (2007) 110 (11): 2942.

https://doi.org/10.1182/blood.V110.11.2942.2942

Published: 2007

Journal Articles

Inherited and Acquired Thrombophilia in Children and Young Adults with Bcr-Abl Negative Chronic Myeloproliferative Disorders.

Fiorina Giona, MD, Giovanna Palumbo, MD, Patrizia Pignoloni, Angela Amendola, MD, Antonio Chistolini, MD, Anna Maria Testi, MD, Maria Luisa Moleti, MD, Robert Foa, Maria Gabriella Mazzucconi

Blood (2005) 106 (11): 4949.

https://doi.org/10.1182/blood.V106.11.4949.4949

Published: 2005

Journal Articles

GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children

Anna Maria Testi, Andrea Biondi, Francesco Lo Coco, Maria Luisa Moleti, Fiorina Giona, Marco Vignetti, Giuseppe Menna, Franco Locatelli, Andrea Pession, Elena Barisone, Giulio De Rossi, Daniela Diverio, Concetta Micalizzi, Maurizio Aricò, Giuseppe Basso, Robert Foa, Franco Mandelli

Blood (2005) 106 (2): 447–453.

https://doi.org/10.1182/blood-2004-05-1971

Published: 2005

NARROW

Chronic Thrombocytopenia in Children: What Could It Hide?

Role of Blinatumomab in Minimal Residual Disease and Hematologic Relapsed/Refractory Adult Acute Lymphoblastic Leukemia Patients Treated over 5 Years. a Single Center Experience

Specific Guidelines Including Multidisciplinary Approach Is Critical of Management of Langerhans Cell Histiocytosis in Adults

Next-Generation Sequencing (NGS) in Childhood Myeloproliferative Diseases (MPD)

Intermittent Imatinib Mesylate in Children with Chronic Myeloid Leukemia: Results and Outcome

Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib— the Italian Experience

Management of Chronic Myeloid Leukemia in Children and Adolescents According to Local Guidelines.the Italian Experience

Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. the Italian Experience

Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience

Primary Trombocythemia in Children and Adolescents Includes Different Subtypes Compared to Adult Essential Thrombocythemia

Can Children and Adolescents With Chronic Myelogenous Leukemia Be Cured Without Stem Cell Transplant? A Single Center Experience

Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome

Incidence and Predictors of Early Treatment-Related Mortality In Pediatric Acute Lymphoblastic Leukemia In Baghdad (Iraq)

GIMEMA-AIEOP AIDA Protocols for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) In Children: Analysis of 247 Patients Enrolled In Two Sequential Italian Multicenter Trials

Clinical and Biological Features, Treatment and Long-Term Outcome of 65 Children with Ph- Myeloprolipherative Disorders (MPD).

Inherited and Acquired Thrombophilic Abnormalities in Patients Aged <20 Years with Bcr-Abl Negative Chronic Myeloproliferative Disorders

Imatinib Mesylate Induces High Complete Cytogenetic and Molecular Response Rates in Children and Adolescents with Philadelphia Chromosome-Positive (Ph + ) Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP)

Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.

Inherited and Acquired Thrombophilia in Children and Young Adults with Bcr-Abl Negative Chronic Myeloproliferative Disorders.

GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only